Physician profile
Robert J Bess
NPI 1083672570
$28,842.32
in general payments reported to CMS, 2019-2025
21 companies · $8,951 in 2025
The $8,951 reported for 2025 was more than what 87% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,044 · 2020: $188 · 2021: $6,442 · 2022: $1,649 · 2023: $1,000 · 2024: $9,568 · 2025: $8,951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $15K · Food and Beverage: $1,911 · Travel and Lodging: $1,380 · Consulting Fee: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $15,227.29 |
| Food and Beverage | $1,911.31 |
| Travel and Lodging | $1,379.95 |
| Consulting Fee | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $15,227.29 | 2024-2025 | Versatie |
| Gemini Mountain Medical, LLC | $4,202.70 | 2021-2024 | |
| Alphatec Spine, INC | $3,540.90 | 2021-2022 | |
| Si-Bone, INC. | $1,984.20 | 2019-2023 | |
| Mml US, INC. | $1,709.14 | 2025 | Reactiv8 |
| Orthofix Medical, INC. | $697.10 | 2021 | |
| Arthrex, INC. | $665.67 | 2024 | |
| Stryker Corporation | $204.00 | 2021-2022 | |
| Cerapedics INC. | $119.73 | 2020 | |
| Vb Spine LLC | $106.92 | 2025 | Capri Corpectomy Cage System |
| Illuminoss Medical, INC. | $96.74 | 2024 | |
| Abbott Laboratories | $49.33 | 2022 | |
| Depuy Synthes Sales INC. | $44.96 | 2019 | |
| Avanos Medical | $40.03 | 2025 | On-Q Pump and Accessories |
| Nexxt Spine LLC | $37.26 | 2025 | Nexxt Spine Mcs Technology |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arteriocyte Medical Systems, INC. | $28.14 | 2020 | |
| Zimmer Biomet Holdings, INC. | $27.04 | 2020 | |
| Providence Medical Technology, INC. | $17.88 | 2025 | |
| Lemaitre Vascular, INC. | $15.20 | 2019 | |
| Theragen, INC. | $14.92 | 2024 | Actastim-S |
| Bioventus LLC | $13.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.